Vutiglabridin

DB18781InvestigationalSmall molecule

Vutiglabridin: Overview.

Mechanism: Pharmacologically active on Serum paraoxonase/arylesterase 2
Curator reviewed
Formula / weight: C₂₂H₂₆O₄ · 354.446 g/mol (avg)
Code names: HSG4112

Resolves to

Compound

Structure

InChIKeyIUXJXQLTUMGHHL-UHFFFAOYSA-NSMILESCCOC1=CC=C(C2COC3=C(C2)C=CC2=C3CCC(C)(C)O2)C(O)=C1

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vutiglabridin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.